Monte Rosa Therapeutics Market Sentiment

Monte Rosa Therapeutics Inc

GLUENASDAQ

Trade with Public

$15.82

-0.06-0.38%

At close: Aug 10, 5:00 PM EST

$15.82

N/A

After Hours: 4:00 PM EST

Earnings: Q2 2026 Earnings were released on Thu Aug 6th, before the market open

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Monte Rosa Therapeutics Market Sentiment

Market sentiment signals for Monte Rosa Therapeutics (GLUE): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Overweight

Short Interest▲ 20.7% short float

Options Flow▼ 2.42 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Overweight

8 analysts

Options Flow (P/C)

2.42

More puts — Bearish

252 calls · 611 puts

Avg Consensus PT

$25

+58.9%

Highest Price Target

$37

+133.9%

Piper Sandler

Lowest Price Target

$11

-30.5%

JP Morgan

Short Interest

20.7%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 7, 2026	JP Morgan	Brian Cheng—	+70.7%	$31 → $27	Maintained	Overweight
Aug 7, 2026	Guggenheim	Michael Schmidt—	+77.0%	$35 → $28	Maintained	Buy
Aug 7, 2026	Wells Fargo	Derek Archila—	+70.7%	$29 → $27	Maintained	Overweight
Aug 3, 2026	Wedbush	Robert Driscoll—	+70.7%	$37 → $27	Maintained	Outperform
Jun 30, 2026	Guggenheim	Michael Schmidt—	+121.2%	$30 → $35	Maintained	Buy
May 11, 2026	JP Morgan	Brian Cheng—	+96.0%	$30 → $31	Maintained	Overweight
Mar 18, 2026	Guggenheim	Michael Schmidt—	+89.6%	$34 → $30	Maintained	Buy
Mar 18, 2026	Wells Fargo	Derek Archila—	+83.3%	$30 → $29	Maintained	Overweight
Jan 14, 2026	Piper Sandler	Edward Tenthoff—	+133.9%	$28 → $37	Maintained	Overweight
Jan 8, 2026	Wells Fargo	Derek Archila—	+89.6%	$22 → $30	Maintained	Overweight
Jan 8, 2026	Guggenheim	Michael Schmidt—	+114.9%	$16 → $34	Maintained	Buy
Dec 16, 2025	Wells Fargo	Derek Archila—	+39.1%	$13 → $22	Upgrade	Equal-Weight→Overweight
Nov 7, 2025	Wells Fargo	Derek Archila—	-17.8%	$10 → $13	Maintained	Equal-Weight
Mar 21, 2025	Wells Fargo	Derek Archila—	-36.8%	$11 → $10	Maintained	Equal-Weight
Mar 21, 2025	Wedbush	Robert Driscoll—	+7.5%	$15 → $17	Maintained	Outperform
Mar 12, 2025	LifeSci Capital	——	+20.1%	$19	Initiate	Outperform
Dec 19, 2024	Wells Fargo	Derek Archila—	-30.5%	$14 → $11	Downgrade	Overweight→Equal-Weight
Nov 8, 2024	Wells Fargo	Derek Archila—	-11.5%	$17 → $14	Maintained	Overweight
Sep 12, 2024	Wedbush	Robert Driscoll—	-30.5%	$11 → $11	Maintained	Outperform
Aug 12, 2024	Wells Fargo	Derek Archila—	+7.5%	$18 → $17	Maintained	Overweight
Jun 28, 2024	Piper Sandler	Edward Tenthoff—	+1.1%	$16 → $16	Maintained	Overweight
May 22, 2024	Wedbush	Robert Driscoll—	-30.5%	$11 → $11	Maintained	Outperform
Feb 15, 2024	Wedbush	Robert Driscoll—	-30.5%	$11	Initiate	Outperform
Oct 19, 2023	JP Morgan	Eric Joseph—	-30.5%	$31 → $11	Maintained	Overweight
Aug 11, 2023	Credit Suisse	Richard Law—	-30.5%	$11	Maintained	Neutral